Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA approval in early-mid 2023. The capital raised will also assist in facilitating market entry into these jurisdictions.
Read more in the media release: 221128 Microbio closes latest investment round after surpassing $3.5m target